Cargando…
A blinded clinical study using a subepidermal moisture biocapacitance measurement device for early detection of pressure injuries
This study aimed to evaluate the sensitivity and specificity of subepidermal moisture (SEM), a biomarker employed for early detection of pressure injuries (PI), compared to the “Gold Standard” of clinical skin and tissue assessment (STA), and to characterize the timing of SEM changes relative to the...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217158/ https://www.ncbi.nlm.nih.gov/pubmed/31965682 http://dx.doi.org/10.1111/wrr.12790 |
_version_ | 1783532558097580032 |
---|---|
author | Okonkwo, Henry Bryant, Ruth Milne, Jeanette Molyneaux, Donna Sanders, Julie Cunningham, Glen Brangman, Sharon Eardley, William Chan, Garrett K. Mayer, Barbara Waldo, Mary Ju, Barbara |
author_facet | Okonkwo, Henry Bryant, Ruth Milne, Jeanette Molyneaux, Donna Sanders, Julie Cunningham, Glen Brangman, Sharon Eardley, William Chan, Garrett K. Mayer, Barbara Waldo, Mary Ju, Barbara |
author_sort | Okonkwo, Henry |
collection | PubMed |
description | This study aimed to evaluate the sensitivity and specificity of subepidermal moisture (SEM), a biomarker employed for early detection of pressure injuries (PI), compared to the “Gold Standard” of clinical skin and tissue assessment (STA), and to characterize the timing of SEM changes relative to the diagnosis of a PI. This blinded, longitudinal, prospective clinical study enrolled 189 patients (n = 182 in intent‐to‐treat [ITT]) at acute and post‐acute sites (9 USA, 3 UK). Data were collected from patients' heels and sacrums using a biocapacitance measurement device beginning at admission and continuing for a minimum of 6 days to: (a) the patient developing a PI, (b) discharge from care, or (c) a maximum of 21 days. Standard of care clinical interventions prevailed, uninterrupted. Principal investigators oversaw the study at each site. Blinded Generalists gathered SEM data, and blinded Specialists diagnosed the presence or absence of PIs. Of the ITT population, 26.4% developed a PI during the study; 66.7% classified as Stage 1 injuries, 23% deep tissue injuries, the remaining being Stage 2 or Unstageable. Sensitivity was 87.5% (95% CI: 74.8%‐95.3%) and specificity was 32.9% (95% CI: 28.3%‐37.8%). Area under the receiver operating characteristic curve (AUC) was 0.6713 (95% CI 0.5969‐0.7457, P < .001). SEM changes were observed 4.7 (± 2.4 days) earlier than diagnosis of a PI via STA alone. Latency between the SEM biomarker and later onset of a PI, in combination with standard of care interventions administered to at‐risk patients, may have confounded specificity. Aggregate SEM sensitivity and specificity and 67.13% AUC exceeded that of clinical judgment alone. While acknowledging specificity limitations, these data suggest that SEM biocapacitance measures can complement STAs, facilitate earlier identification of the risk of specific anatomies developing PIs, and inform earlier anatomy‐specific intervention decisions than STAs alone. Future work should include cost‐consequence analyses of SEM informed interventions. |
format | Online Article Text |
id | pubmed-7217158 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72171582020-05-13 A blinded clinical study using a subepidermal moisture biocapacitance measurement device for early detection of pressure injuries Okonkwo, Henry Bryant, Ruth Milne, Jeanette Molyneaux, Donna Sanders, Julie Cunningham, Glen Brangman, Sharon Eardley, William Chan, Garrett K. Mayer, Barbara Waldo, Mary Ju, Barbara Wound Repair Regen Original Research‐clinical Science This study aimed to evaluate the sensitivity and specificity of subepidermal moisture (SEM), a biomarker employed for early detection of pressure injuries (PI), compared to the “Gold Standard” of clinical skin and tissue assessment (STA), and to characterize the timing of SEM changes relative to the diagnosis of a PI. This blinded, longitudinal, prospective clinical study enrolled 189 patients (n = 182 in intent‐to‐treat [ITT]) at acute and post‐acute sites (9 USA, 3 UK). Data were collected from patients' heels and sacrums using a biocapacitance measurement device beginning at admission and continuing for a minimum of 6 days to: (a) the patient developing a PI, (b) discharge from care, or (c) a maximum of 21 days. Standard of care clinical interventions prevailed, uninterrupted. Principal investigators oversaw the study at each site. Blinded Generalists gathered SEM data, and blinded Specialists diagnosed the presence or absence of PIs. Of the ITT population, 26.4% developed a PI during the study; 66.7% classified as Stage 1 injuries, 23% deep tissue injuries, the remaining being Stage 2 or Unstageable. Sensitivity was 87.5% (95% CI: 74.8%‐95.3%) and specificity was 32.9% (95% CI: 28.3%‐37.8%). Area under the receiver operating characteristic curve (AUC) was 0.6713 (95% CI 0.5969‐0.7457, P < .001). SEM changes were observed 4.7 (± 2.4 days) earlier than diagnosis of a PI via STA alone. Latency between the SEM biomarker and later onset of a PI, in combination with standard of care interventions administered to at‐risk patients, may have confounded specificity. Aggregate SEM sensitivity and specificity and 67.13% AUC exceeded that of clinical judgment alone. While acknowledging specificity limitations, these data suggest that SEM biocapacitance measures can complement STAs, facilitate earlier identification of the risk of specific anatomies developing PIs, and inform earlier anatomy‐specific intervention decisions than STAs alone. Future work should include cost‐consequence analyses of SEM informed interventions. John Wiley & Sons, Inc. 2020-01-21 2020 /pmc/articles/PMC7217158/ /pubmed/31965682 http://dx.doi.org/10.1111/wrr.12790 Text en © 2020 The Authors. Wound Repair and Regeneration published by Wiley Periodicals, Inc. on behalf of by the Wound Healing Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research‐clinical Science Okonkwo, Henry Bryant, Ruth Milne, Jeanette Molyneaux, Donna Sanders, Julie Cunningham, Glen Brangman, Sharon Eardley, William Chan, Garrett K. Mayer, Barbara Waldo, Mary Ju, Barbara A blinded clinical study using a subepidermal moisture biocapacitance measurement device for early detection of pressure injuries |
title | A blinded clinical study using a subepidermal moisture biocapacitance measurement device for early detection of pressure injuries |
title_full | A blinded clinical study using a subepidermal moisture biocapacitance measurement device for early detection of pressure injuries |
title_fullStr | A blinded clinical study using a subepidermal moisture biocapacitance measurement device for early detection of pressure injuries |
title_full_unstemmed | A blinded clinical study using a subepidermal moisture biocapacitance measurement device for early detection of pressure injuries |
title_short | A blinded clinical study using a subepidermal moisture biocapacitance measurement device for early detection of pressure injuries |
title_sort | blinded clinical study using a subepidermal moisture biocapacitance measurement device for early detection of pressure injuries |
topic | Original Research‐clinical Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217158/ https://www.ncbi.nlm.nih.gov/pubmed/31965682 http://dx.doi.org/10.1111/wrr.12790 |
work_keys_str_mv | AT okonkwohenry ablindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT bryantruth ablindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT milnejeanette ablindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT molyneauxdonna ablindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT sandersjulie ablindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT cunninghamglen ablindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT brangmansharon ablindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT eardleywilliam ablindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT changarrettk ablindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT mayerbarbara ablindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT waldomary ablindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT jubarbara ablindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT okonkwohenry blindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT bryantruth blindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT milnejeanette blindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT molyneauxdonna blindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT sandersjulie blindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT cunninghamglen blindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT brangmansharon blindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT eardleywilliam blindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT changarrettk blindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT mayerbarbara blindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT waldomary blindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries AT jubarbara blindedclinicalstudyusingasubepidermalmoisturebiocapacitancemeasurementdeviceforearlydetectionofpressureinjuries |